Mitigating the opioid epidemic is St. Petersburg-based microNeb’s primary focus. However, a clinical-stage pharmaceutical company believes the medical technology startup’s novel inhaler could eliminate the need...
Oragenics Inc. (NYSE: OGEN), a Tampa-based biotech firm, has raised $20 million from the sale of common stock and will use some of the funding to...
